[HTML][HTML] Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis

E Landfeldt, R Thompson, T Sejersen… - European journal of …, 2020 - Springer
Several studies indicate that prognosis for survival in Duchenne muscular dystrophy (DMD)
has improved in recent decades. However, published evidence is inconclusive and some …

[HTML][HTML] The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review

SM Szabo, RM Salhany, A Deighton… - Orphanet Journal of …, 2021 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited
neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The …

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

G Solé, E Salort-Campana, Y Pereon, T Stojkovic… - Revue …, 2020 - Elsevier
In France, the epidemic phase of COVID-19 caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) began in February 2020 and resulted in the implementation of …

Duchenne muscular dystrophy and caregiver burden: a systematic review

E Landfeldt, J Edström, F Buccella… - … Medicine & Child …, 2018 - Wiley Online Library
Aim To conduct a systematic literature review of caregiver burden in Duchenne muscular
dystrophy (DMD). Method We searched Embase, Web of Science, and PubMed for full‐text …

[HTML][HTML] Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

LS Conklin, JM Damsker, EP Hoffman, WJ Jusko… - Pharmacological …, 2018 - Elsevier
We report a first-in-patient study of vamorolone, a first-in-class dissociative steroidal anti-
inflammatory drug, in Duchenne muscular dystrophy. This 2-week, open-label Phase IIa …

[HTML][HTML] Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History …

E Mercuri, AN Osorio, F Muntoni, F Buccella… - Journal of …, 2023 - Springer
Abstract Objective Strategic Targeting of Registries and International Database of
Excellence (STRIDE) is an ongoing, international, multicenter registry of real-world ataluren …

[HTML][HTML] Duchenne muscular dystrophy in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact

M Orso, A Migliore, B Polistena, E Russo, F Gatto… - PLoS …, 2023 - journals.plos.org
Objective This systematic review aims to update the evidence on Duchenne muscular
dystrophy (DMD) in Italy, describing the epidemiology, quality of life (QoL) of patients and …

Evidence-based consensus and systematic review on reducing the time to diagnosis of Duchenne muscular dystrophy

A Aartsma-Rus, M Hegde, T Ben-Omran… - The Journal of …, 2019 - jpeds.com
Methods The Delphi Consensus Initiative presented here is focused on how to reduce the
time to diagnosis of DMD. The development process for this initiative is summarized in …

Anesthetic consideration for neuromuscular diseases

JA Katz, GS Murphy - Current Opinion in Anesthesiology, 2017 - journals.lww.com
Anesthetic consideration for neuromuscular diseases : Current Opinion in Anesthesiology
Anesthetic consideration for neuromuscular diseases : Current Opinion in Anesthesiology Log …

Long-term ventilation in neuromuscular patients: review of concerns, beliefs, and ethical dilemmas

C Crimi, P Pierucci, A Carlucci, A Cortegiani… - Respiration, 2019 - karger.com
Background: Noninvasive mechanical ventilation (NIV) is an effective treatment in patients
with neuromuscular diseases (NMD) to improve symptoms, quality of life, and survival …